β Agonist Delivery by High-Flow Nasal Cannula During COPD Exacerbation.

BACKGROUND: Whereas high-flow nasal cannula (HFNC) oxygen therapy is increasingly used in patients with exacerbation of COPD, the effectiveness of β2 agonist nebulization through HFNC has been poorly assessed. We hypothesized that salbutamol vibrating-mesh nebulization through HFNC improves pulmonar...

Descripción completa

Detalles Bibliográficos

Publicado en:	Respiratory Care Vol. 67; no. 1; pp. 9 - 16
Autores principales:	Beuvon, Clément, Coudroy, Rémi, Bardin, Justine, Marjanovic, Nicolas, Rault, Christophe, Bironneau, Vanessa, Drouot, Xavier, Robert, René, Thille, Arnaud W., Frat, Jean-Pierre
Formato:	research tables/charts Journal Article
Publicado:	Mary Ann Liebert, Inc. Jan2022
Acceso en línea:	Ver este registro en EBSCOhost